{"created":"2023-06-19T10:28:10.104205+00:00","id":323,"links":{},"metadata":{"_buckets":{"deposit":"f769a02d-e3e2-4138-b04c-f48164a41cdb"},"_deposit":{"created_by":31,"id":"323","owners":[31],"pid":{"revision_id":0,"type":"depid","value":"323"},"status":"published"},"_oai":{"id":"oai:kwmed.repo.nii.ac.jp:00000323","sets":["1709617079800:37:107:369"]},"author_link":["126435"],"item_1694495855422":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_type":"VoR"}]},"item_3_biblio_info_12":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"1991","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"1-4","bibliographicPageEnd":"36","bibliographicPageStart":"29","bibliographicVolumeNumber":"17","bibliographic_titles":[{"bibliographic_title":"Kawasaki medical journal","bibliographic_titleLang":"en"}]}]},"item_3_description_9":{"attribute_name":"記事種別(英)","attribute_value_mlt":[{"subitem_description":"Original Article","subitem_description_language":"en","subitem_description_type":"Other"}]},"item_3_identifier_14":{"attribute_name":"URL","attribute_value_mlt":[{"subitem_identifier_type":"URI","subitem_identifier_uri":"http://igakkai.kms-igakkai.com/wp/wp-content/uploads/1991en/17(1.2.3.4)29-36.1991.pdf"}]},"item_3_relation_20":{"attribute_name":"DOI","attribute_value_mlt":[{"subitem_relation_type_id":{"subitem_relation_type_id_text":"https://doi.org/10.11482/KMJ-E17(1.2.3.4)29-36.1991","subitem_relation_type_select":"DOI"}}]},"item_3_source_id_1":{"attribute_name":"雑誌書誌ID","attribute_value_mlt":[{"subitem_source_identifier":"AA00710169","subitem_source_identifier_type":"NCID"},{"subitem_source_identifier":"AA12029005","subitem_source_identifier_type":"NCID"}]},"item_3_source_id_19":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"0385-0234","subitem_source_identifier_type":"PISSN"},{"subitem_source_identifier":"2434-3404","subitem_source_identifier_type":"EISSN"}]},"item_3_text_7":{"attribute_name":"著者所属(英)","attribute_value_mlt":[{"subitem_text_language":"en","subitem_text_value":"Department of Neurology, Kawasaki Medical School"}]},"item_3_textarea_11":{"attribute_name":"抄録(英)","attribute_value_mlt":[{"subitem_textarea_language":"en","subitem_textarea_value":"Saturated very long chain fatty acid (VLCFAs, C22:0 - C28 :0) contents in the sera of 9 adrenoleukodystrophy (ALD) patients, 4 adrenomyeloneuropathy (AMN) patients, and 11 age-matched normal controls were determined by gas chromatography (GC), GC/mass spectrometry (MS) and selected-ion-monitoring (SIM)-GC/MS. The following results were obtained. The C22:0 contents of the ALD and AMN groups were not significantly different from those of the control group. However, the C24: 0 contents of the ALD and AMN groups were respectively, 1.9 and 1.5 times higher than control, and the C26:0 contents of these groups measured by SIM-GC/MS were 7.7 and 7.8 times higher than the control. These contents were about half of those measured by GC alone. The C28 :0 content of human sera could be measured for the first time in this study using SIM-GC/MS. The order of the increasing rate of the individual VLCFAs of ALD and AMN as compared that with the control was as follows, C26 : 0 > C28 : 0 > C24 : 0. "}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"KAWAI, Kingo","creatorNameLang":"en"}],"nameIdentifiers":[{}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2017-01-23"}],"displaytype":"detail","filename":"KJ00010210179.pdf","filesize":[{"value":"729.8 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"KJ00010210179.pdf","objectType":"fulltext","url":"https://kwmed.repo.nii.ac.jp/record/323/files/KJ00010210179.pdf"},"version_id":"aaee4a36-6476-414e-900d-73ea52add11a"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"Saturated very long chain fatty acids","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Adrenoleukodystrophy","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Adrenomyeloneuropathy","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Selected-ion-monitoring gas chromatography/mass spectrometry","subitem_subject_language":"en","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"Very Long Chain Fatty Acid Contents in the Sera of Patients with Adrenoleukodystrophy and Adrenomyeloneuropathy Measured by Selected-Ion-Monitoring Gas Chromatography/Mass Spectrometry","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Very Long Chain Fatty Acid Contents in the Sera of Patients with Adrenoleukodystrophy and Adrenomyeloneuropathy Measured by Selected-Ion-Monitoring Gas Chromatography/Mass Spectrometry","subitem_title_language":"en"}]},"item_type_id":"3","owner":"31","path":["369"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2017-01-23"},"publish_date":"2017-01-23","publish_status":"0","recid":"323","relation_version_is_last":true,"title":["Very Long Chain Fatty Acid Contents in the Sera of Patients with Adrenoleukodystrophy and Adrenomyeloneuropathy Measured by Selected-Ion-Monitoring Gas Chromatography/Mass Spectrometry"],"weko_creator_id":"31","weko_shared_id":-1},"updated":"2023-09-28T00:19:45.262672+00:00"}